Novel Therapeutic Approaches for Pulmonary Manifestations of Systemic Sclerosis

Am J Respir Crit Care Med. 2020 Sep 15;202(6):878-880. doi: 10.1164/rccm.202002-0307RR.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Lung / diagnostic imaging*
  • Lung Diseases, Interstitial / drug therapy*
  • Lung Diseases, Interstitial / etiology*
  • Male
  • Middle Aged
  • Mycophenolic Acid / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Scleroderma, Systemic / complications*
  • Scleroderma, Systemic / drug therapy*

Substances

  • Indoles
  • Protein Kinase Inhibitors
  • nintedanib
  • Mycophenolic Acid